257 related articles for article (PubMed ID: 37508560)
1. A Shiga Toxin B-Subunit-Based Lectibody Boosts T Cell Cytotoxicity towards Gb3-Positive Cancer Cells.
Tomisch J; Busse V; Rosato F; Makshakova ON; Salavei P; Kittel AS; Gillon E; Lataster L; Imberty A; Meléndez AV; Römer W
Cells; 2023 Jul; 12(14):. PubMed ID: 37508560
[TBL] [Abstract][Full Text] [Related]
2. A bispecific, crosslinking lectibody activates cytotoxic T cells and induces cancer cell death.
Rosato F; Pasupuleti R; Tomisch J; Meléndez AV; Kolanovic D; Makshakova ON; Wiltschi B; Römer W
J Transl Med; 2022 Dec; 20(1):578. PubMed ID: 36494671
[TBL] [Abstract][Full Text] [Related]
3. Novel lectin-based chimeric antigen receptors target Gb3-positive tumour cells.
Meléndez AV; Velasco Cárdenas RM; Lagies S; Strietz J; Siukstaite L; Thomas OS; Tomisch J; Weber W; Kammerer B; Römer W; Minguet S
Cell Mol Life Sci; 2022 Sep; 79(10):513. PubMed ID: 36097202
[TBL] [Abstract][Full Text] [Related]
4. Repurposing the Pentameric B-Subunit of Shiga Toxin for Gb3-Targeted Immunotherapy of Colorectal Cancer by Rhamnose Conjugation.
Liu Z; Li X; Lu Z; Qin X; Hong H; Zhou Z; Pieters RJ; Shi J; Wu Z
J Pharm Sci; 2022 Oct; 111(10):2719-2729. PubMed ID: 35905973
[TBL] [Abstract][Full Text] [Related]
5. Differential recognition of lipid domains by two Gb3-binding lectins.
Schubert T; Sych T; Madl J; Xu M; Omidvar R; Patalag LJ; Ries A; Kettelhoit K; Brandel A; Mely Y; Steinem C; Werz DB; Thuenauer R; Römer W
Sci Rep; 2020 Jun; 10(1):9752. PubMed ID: 32546842
[TBL] [Abstract][Full Text] [Related]
6. Gastric Adenocarcinomas Express the Glycosphingolipid Gb3/CD77: Targeting of Gastric Cancer Cells with Shiga Toxin B-Subunit.
Geyer PE; Maak M; Nitsche U; Perl M; Novotny A; Slotta-Huspenina J; Dransart E; Holtorf A; Johannes L; Janssen KP
Mol Cancer Ther; 2016 May; 15(5):1008-17. PubMed ID: 26826119
[TBL] [Abstract][Full Text] [Related]
7. Potent in vitro antitumor activity of B-subunit of Shiga toxin conjugated to the diphtheria toxin against breast cancer.
Mohseni Z; Sedighian H; Halabian R; Amani J; Behzadi E; Imani Fooladi AA
Eur J Pharmacol; 2021 May; 899():174057. PubMed ID: 33753109
[TBL] [Abstract][Full Text] [Related]
8. Blood group P1 antigen-bearing glycoproteins are functional but less efficient receptors of Shiga toxin than conventional glycolipid-based receptors.
Morimoto K; Suzuki N; Tanida I; Kakuta S; Furuta Y; Uchiyama Y; Hanada K; Suzuki Y; Yamaji T
J Biol Chem; 2020 Jul; 295(28):9490-9501. PubMed ID: 32409578
[TBL] [Abstract][Full Text] [Related]
9. Tumor delivery of ultrasound contrast agents using Shiga toxin B subunit.
Couture O; Dransart E; Dehay S; Nemati F; Decaudin D; Johannes L; Tanter M
Mol Imaging; 2011 Apr; 10(2):135-43. PubMed ID: 21439258
[TBL] [Abstract][Full Text] [Related]
10. Rapid method to detect shiga toxin and shiga-like toxin I based on binding to globotriosyl ceramide (Gb3), their natural receptor.
Ashkenazi S; Cleary TG
J Clin Microbiol; 1989 Jun; 27(6):1145-50. PubMed ID: 2666433
[TBL] [Abstract][Full Text] [Related]
11. Shiga toxin binding alters lipid packing and the domain structure of Gb
Bosse M; Sibold J; Scheidt HA; Patalag LJ; Kettelhoit K; Ries A; Werz DB; Steinem C; Huster D
Phys Chem Chem Phys; 2019 Jul; 21(28):15630-15638. PubMed ID: 31268447
[TBL] [Abstract][Full Text] [Related]
12. Membrane invagination induced by Shiga toxin B-subunit: from molecular structure to tube formation.
Pezeshkian W; Hansen AG; Johannes L; Khandelia H; Shillcock JC; Kumar PB; Ipsen JH
Soft Matter; 2016 Jun; 12(23):5164-71. PubMed ID: 27070906
[TBL] [Abstract][Full Text] [Related]
13. Shiga toxin and its use in targeted cancer therapy and imaging.
Engedal N; Skotland T; Torgersen ML; Sandvig K
Microb Biotechnol; 2011 Jan; 4(1):32-46. PubMed ID: 21255370
[TBL] [Abstract][Full Text] [Related]
14. Histidine-tagged shiga toxin B subunit binding assay: simple and specific determination of gb3 content in mammalian cells.
Shin IS; Nishikawa K; Maruyama H; Ishii S
Chem Pharm Bull (Tokyo); 2006 Apr; 54(4):522-7. PubMed ID: 16595957
[TBL] [Abstract][Full Text] [Related]
15. Lectin-anticancer peptide fusion demonstrates a significant cancer-cell-selective cytotoxic effect and inspires the production of "clickable" anticancer peptide in Escherichia coli.
Pasupuleti R; Riedl S; Saltor Núñez L; Karava M; Kumar V; Kourist R; Turnbull WB; Zweytick D; Wiltschi B
Protein Sci; 2023 Dec; 32(12):e4830. PubMed ID: 37916438
[TBL] [Abstract][Full Text] [Related]
16. Tumor Targeting with Bacterial Shiga Toxin B Subunit in Genetic Porcine Models for Colorectal Cancer and Osteosarcoma.
Ehrenfeld M; Schrade A; Flisikowska T; Perl M; Hirsch ND; Sichler A; Geyer L; Flisikowski K; Wilhelm D; Schober SJ; Johannes L; Schnieke A; Janssen KP
Mol Cancer Ther; 2022 Apr; 21(4):686-699. PubMed ID: 35086950
[TBL] [Abstract][Full Text] [Related]
17. STxB as an Antigen Delivery Tool for Mucosal Vaccination.
Tartour E; Johannes L
Toxins (Basel); 2022 Mar; 14(3):. PubMed ID: 35324699
[TBL] [Abstract][Full Text] [Related]
18. Shiga toxin binding to glycolipids and glycans.
Gallegos KM; Conrady DG; Karve SS; Gunasekera TS; Herr AB; Weiss AA
PLoS One; 2012; 7(2):e30368. PubMed ID: 22348006
[TBL] [Abstract][Full Text] [Related]
19. Human breast cancer and lymph node metastases express Gb3 and can be targeted by STxB-vectorized chemotherapeutic compounds.
Stimmer L; Dehay S; Nemati F; Massonnet G; Richon S; Decaudin D; Klijanienko J; Johannes L
BMC Cancer; 2014 Dec; 14():916. PubMed ID: 25476116
[TBL] [Abstract][Full Text] [Related]
20. Pathogenesis of shigella diarrhea. XI. Isolation of a shigella toxin-binding glycolipid from rabbit jejunum and HeLa cells and its identification as globotriaosylceramide.
Jacewicz M; Clausen H; Nudelman E; Donohue-Rolfe A; Keusch GT
J Exp Med; 1986 Jun; 163(6):1391-404. PubMed ID: 3519828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
